"Serum Albumin, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum albumin from humans. It is an essential carrier of both endogenous substances, such as fatty acids and BILIRUBIN, and of XENOBITOICS in the blood.
| Descriptor ID |
D000075462
|
| MeSH Number(s) |
D12.776.034.841.603 D12.776.124.727.906
|
| Concept/Terms |
Serum Albumin, Human- Serum Albumin, Human
- Albumin, Human Serum
- Human Serum Albumin
- Albumin Human
- Human, Albumin
- Human Albumin
- Albumin, Human
|
Below are MeSH descriptors whose meaning is more general than "Serum Albumin, Human".
Below are MeSH descriptors whose meaning is more specific than "Serum Albumin, Human".
This graph shows the total number of publications written about "Serum Albumin, Human" by people in this website by year, and whether "Serum Albumin, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Albumin, Human" by people in Profiles.
-
Surface modification of polypropylene surgical meshes for improving adhesion with poloxamine hydrogel adhesive. J Biomed Mater Res B Appl Biomater. 2019 May; 107(4):1047-1055.
-
Bayesian dose selection design for a binary outcome using restricted response adaptive randomization. Trials. 2017 09 08; 18(1):420.
-
Evaluation of Blood Biomarkers Associated with Risk of Malnutrition in Older Adults: A Systematic Review and Meta-Analysis. Nutrients. 2017 Aug 03; 9(8).
-
Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci. 2015 Jan; 143(1):136-46.
-
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
-
S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys. 2006 Jun 01; 450(1):1-8.